Search results for "CANNABIS"

showing 10 items of 174 documents

Childhood trauma and substance use underlying psychosis: a systematic review

2020

[EN] Background: Schizophrenia spectrum disorders (SSD) are mental diseases caused by a combination of genetic susceptibility and a number of environmental factors. Among these factors, the role of traumatic events suffered in childhood, as well as that of substance use, have been of particular research interest. Objectives: To conduct a systematic review to clarify whether there is an interaction between childhood trauma and substance use related to the diagnosis or symptoms of SSD. It was also the objective of this review to collate the associations that may exist between the three variables of the study (trauma, substance use and psychosis). Methods: We conducted a systematic search resu…

PsychosisSubstances useRC435-571Poison controlEsquizofreniaReview Article药物滥用Cannabis useSuicide preventionOccupational safety and healthChildhood traumaConsumo de cannabis思觉失调Injury preventionmedicinePsicosisPsychiatryWindow of opportunitybusiness.industryHuman factors and ergonomicsConsumo de sustanciasmedicine.diseasePsychosis• Schizophrenia is caused by a combination of genetic susceptibility and a number of environmental factors. Traumatic events suffered in childhood as well as substance use have been of particular interest.• Our results reveal a positive association between traumatic experiences in childhood and drug use and their interaction with schizophrenia spectrum disorders.• Detecting cases of childhood trauma as well as cases of trauma associated with substance use could be useful for the primary prevention of some psychiatric diseases such as psychosis.大麻使用精神分裂症SchizophreniaTrauma infantilSchizophreniabusiness童年创伤Clinical psychology
researchProduct

O12.4. SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT F…

2018

Abstract Background Cannabis use remains the most widely used recreational drug worldwide. Following from several USA states legalisation policies, European countries are reconsidering their cannabis laws. While a significant amount of Epidemiological evidence has reported that cannabis use increases the risk of psychosis it is still unclear: 1) what underpins individual differences in developing a psychotic disorder following cannabis use; 2) if variations in availability of cannabis have affected rate of Psychotic disorders across Europe. Methods Using detailed data on lifetime pattern of cannabis use from the EUGEI first episode case-control study (N=2300) and the available Incidence rat…

Psychosismedicine.medical_specialtybiologymedicine.diseasebiology.organism_classification030227 psychiatryAbstracts03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineO12. Oral Session: Socio-Economic/EnvironmentmedicineCannabisPsychiatryPsychology030217 neurology & neurosurgerySchizophrenia Bulletin
researchProduct

Occurrence of illicit drugs in two wastewater treatment plants in the South of Italy

2017

In this study the occurrence and the behavior of illicit drugs and their metabolites have been investigated for two wastewater treatment plants (WWTPs) (namely, WWTP-1 and WWTP-2) located in Sicily (island of Italy). Samples were analyzed for methamphetamine, cocaine (COC), 3,4-methylenedioxymethamphetamine (MDMA), methadone (METH), 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), 3,4-methylenedioxy amphetamine (MDA); 3,4-methylenedioxy ethylamphetamine (MDEA), 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THC-COOH) and Benzoylecgonine (BEG). The BEG, COC, MOR and THC-COOH were found at the highest concentration in both WWTPs. The Wastewater-based epidemiology calculation for BEG, COC…

PyrrolidinesHealth Toxicology and Mutagenesis0208 environmental biotechnology02 engineering and technologyWastewater010501 environmental sciencesSettore MED/42 - Igiene Generale E ApplicataWaste Disposal Fluid01 natural sciencesMethamphetamineIllicit drugchemistry.chemical_compoundCocaineSettore BIO/10 - BiochimicaCannabidiolWater treatmentDronabinolSicilyDrug behavioreducation.field_of_studybiologyTraditional medicineChemistry (all)MDMAGeneral MedicineMethamphetaminePollutionContaminants of emerging concernSubstance Abuse DetectionDrug CombinationsBenzoylecgoninemedicine.drugEnvironmental EngineeringPopulationmedicineHumansEnvironmental Chemistryeducation0105 earth and related environmental sciencesSettore ICAR/03 - Ingegneria Sanitaria-AmbientaleIllicit Drugsbusiness.industryAmphetaminesCodeinePublic Health Environmental and Occupational HealthGeneral Chemistrybiology.organism_classificationEthylamphetamine020801 environmental engineeringAmphetaminechemistryCannabisbusinessWater Pollutants ChemicalMethadoneChemosphere
researchProduct

Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infecte…

2018

International audience; BACKGROUND:Direct-acting antivirals (DAA) have dramatically increased HCV cure rates with minimal toxicity in HIV-HCV co-infected patients. This study aimed to compare the socio-behavioral characteristics of patients initiating pegylated-interferon (PEG-IFN)-based HCV treatment with those of patients initiating DAA-based treatment.METHODS:ANRS CO13 HEPAVIH is a national multicenter prospective cohort started in 2005, which enrolled 1,859 HIV-HCV co-infected patients followed up in French hospital outpatient units. Both clinical/biological and socio-behavioral data were collected during follow-up. We selected patients with socio-behavioral data available before HCV tr…

RNA virusesMaleHealth BehaviorSocial Scienceslcsh:MedicineHIV InfectionsHepacivirusGeographical locationsChronic Liver Disease0302 clinical medicineRisk FactorsPrevalencePsychologyAlcohol consumptionProspective Studies030212 general & internal medicineYoung adultProspective cohort studylcsh:SciencePathology and laboratory medicinemedia_commonChronic hepatitisDrug injectionClinical Trials as TopicMultidisciplinarybiologyPharmaceuticsCoinfectionHepatitis C virusLiver Diseasesvirus diseasesMedical microbiologyMiddle AgedPrognosisHepatitis CAddicts3. Good healthEuropeBehavioral PharmacologyDrug usersVirusesCohortFemale030211 gastroenterology & hepatologyDrug therapyFrancePathogensResearch ArticleAdultDrugmedicine.medical_specialtySubstance-Related Disordersmedia_common.quotation_subjectLiver fibrosisAddictionContext (language use)Gastroenterology and HepatologyMicrobiologyAntiviral AgentsYoung Adult03 medical and health sciencesPharmacotherapyRecreational Drug UseInternal medicinemedicineHumansEuropean UnionNutritionAgedCannabisMedicine and health sciencesPharmacologyBiology and life sciencesFlavivirusesbusiness.industrylcsh:ROrganismsViral pathogensHIVbiology.organism_classificationHepatitis virusesdigestive system diseasesMicrobial pathogensDiet[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologielcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCannabisPeople and placesbusiness
researchProduct

Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and …

2021

AbstractBackgroundFirst episode psychosis (FEP) patients who use cannabis experience more frequent psychotic and euphoric intoxication experiences compared to controls. It is not clear whether this is consequent to patients being more vulnerable to the effects of cannabis use or to their heavier pattern of use. We aimed to determine whether extent of use predicted psychotic-like and euphoric intoxication experiences in patients and controls and whether this differs between groups.MethodsWe analysed data on patients who had ever used cannabis (n = 655) and controls who had ever used cannabis (n = 654) across 15 sites from six countries in the EU-GEI study (2010–2015). We used multiple regres…

SYMPTOMSPoison control0302 clinical medicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.substance abuseApplied PsychologyPOPULATIONRISKeducation.field_of_studybiologyHuman factors and ergonomicsCannabis usePsychotomimeticSubstance abusePsychiatry and Mental healthSchizophreniaPsychotic-like experiencepsychotomimeticmedicine.drugmedicine.medical_specialtyDISORDERSPopulationFrequency of use03 medical and health sciencesFirst episode psychosisInjury preventionmedicineHumansAssociation (psychology)PsychiatryeducationSettore MED/25 - PsichiatriaDELUSIONAL IDEATIONEffects of cannabisMETAANALYSISCannabisCannabinoid Receptor Agonistsbusiness.industryPsychotic-like experiencesbiology.organism_classificationmedicine.disease030227 psychiatryschizophreniaMulti nationalPsychotic DisordersHallucinogensPOTENCYCannabisbusiness030217 neurology & neurosurgery
researchProduct

Info-communicationnal approach of medical cannabis self-medication : analysis of figures mobilized in knowledge legitimation within a community dedic…

2022

This thesis proposes an infocommunicational approach to self-medication with medical cannabis. We question the logic of knowledge legitimization in a context where the coercive power of the French state is exercised. We seek to understand how the use of cannabis is determined in a radically constrained legislative framework, for users in a recreational or self-medication approach, but also for doctors and patients in a medical approach. To do this, we analyze the processes of knowledge legitimization that allow the development of practical know-how allowing individuals to consume cannabis in a self-medication approach within clandestine health communities of practice, supported by participa…

Santé en ligneSavoir-FaireCommunautésCommunitiesKnow howExpertiseOnline HealthLegitimationLégitimation[SHS.INFO] Humanities and Social Sciences/Library and information sciencesCannabis
researchProduct

FORENSIC INVESTIGATION OF KERATIN MATRIX: DEVELOPMENT OF A METHOD BY TURBOFLOW™ HPLC-MS/MS FOR CANNABINOIDS QUANTITATIVE ANALYSIS

2016

The products of cannabis are the most frequently used illicit drugs of abuse detected in workplace drug-testing programs or in cases of driving under the influence of drugs. For this reason, there is a great need for sensitive and specific methods which can confirm the chronic exposure and which take account of the cut-off values that have been proposed in Italy by the GTFI Guidelines (Group of Italian Forensic Toxicologists). The method currently more appropriate for quantification of Δ9-Tetrahydrocannabinol (THC) and its major metabolite 11-nor-9-Carboxy-Δ9-THC (THCA) appears to be one that involves HPLC-MS/MS and keratin matrix. The purpose of this work, performed at the Mass Spectrometr…

Settore BIO/10 - BiochimicaCannabis; TurboflowCannabiTurboflow
researchProduct

What does augment the risk to use cannabis on an everyday-basis in psychotic patients?

2017

Introduction There are strong enough evidences of the fact that risk of psychosis is augmented by cannabis use. In a recent analysis, the strongest predictor of case-control status was daily-skunk use, i.e. the ORs for skunk users increase with the frequency of use5. We know also that FEP who smoked cannabis in their lifetime are less neuropsychologically impaired i.e. they have better premorbid and current IQ6. In this study we wanted to test what augments the probability to be everyday users, taking into account premorbid social and academic adjustment and cognition as predictors, along with age at first cannabis-use and % of THC in cannabis used. Methods The sample was made of 834 First …

Settore M-PSI/08 - Psicologia ClinicaSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.Settore MED/25 - Psichiatriacannabis abuse age at first use psychosis
researchProduct

FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS…

2018

Background: Patients presenting to psychiatric services with their first episode of psychosis (FEP) report higher rates of previous cannabis use than the general population (Donoghue et al., 2011; Myles, Myles and Large, 2016). Evidence suggested that patients suffering from psychosis with a history of cannabis use have an earlier age of onset of psychosis (AOP) than those who never used it (Di Forti et al., 2013). We aim to investigate if the reported association between use of cannabis and AOP is consistent across different countries, once having taken into account different patterns of cannabis use (i.e. frequency of use and age at first use). Methods: We analysed data on patterns of lif…

Settore M-PSI/08 - Psicologia ClinicaSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.age of onset psychosis cannabisSettore MED/25 - Psichiatria
researchProduct

Cannabis consumption and the risk of psychosis

2017

Summary Objectives: Cannabis is the most widely used illicit drug globally and its use has been linked to an increased risk for psychotic disorders. An association between cannabis consumption and psychotic symptoms was consistently reported by several studies. This case-control study aimed to widen the current findings about the impact of cannabis exposure on the risk of psychosis, by investigating the pattern of cannabis consumption in a sample of first-episode of psychosis (FEP) patients compared to healthy controls. Material and methods: 68 individuals who presented for the first time to mental health services of Palermo (Italy) with an ICD-10 diagnosis of psychotic disorders and 74 hea…

Settore M-PSI/08 - Psicologia ClinicaSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.cannabis schizophrenia psychosis tetrahydrocannabinol drug and schizophreniaSettore MED/25 - Psichiatria
researchProduct